Extracellular and intraneuronal HMW-AbetaOs represent a molecular basis of memory loss in Alzheimer's disease model mouse
Authors:
- Ayumi TakamuraATAyumi Takamura
- Yasuhide OkamotoYOYasuhide Okamoto
- Takeshi KawarabayashiTKTakeshi Kawarabayashi
- Tatsuki YokosekiTYTatsuki Yokoseki
- Masao ShibataMSMasao Shibata
- Akihiro MouriAMAkihiro Mouri
- Toshitaka NabeshimaTNToshitaka Nabeshima
- Hui SunHSHui Sun
- Koji AbeKAKoji Abe
- Tsuneo UrisuTUTsuneo Urisu
- Naoki YamamotoNYNaoki Yamamoto
- Mikio ShojiMSMikio Shoji
Open Access
- 6 March 2011
- journal article
- research article
- Published by Springer Nature in Molecular Neurodegeneration
- Vol. 6 (1) , 20
Abstract
Background: Several lines of evidence indicate that memory loss represents a synaptic failure caused by soluble amyloid β (Aβ) oligomers. However, the pathological relevance of Aβ oligomers (AβOs) as the trigger of synaptic or neuronal degeneration, and the possible mechanism underlying the neurotoxic action of endogenous AβOs remain to be determined. Results: To specifically target toxic AβOs in vivo, monoclonal antibodies (1A9 and 2C3) specific to them were generated using a novel design method. 1A9 and 2C3 specifically recognize soluble AβOs larger than 35-mers and pentamers on Blue native polyacrylamide gel electrophoresis, respectively. Biophysical and structural analysis by atomic force microscopy (AFM) revealed that neurotoxic 1A9 and 2C3 oligomeric conformers displayed non-fibrilar, relatively spherical structure. Of note, such AβOs were taken up by neuroblastoma (SH-SY5Y) cell, resulted in neuronal death. In humans, immunohistochemical analysis employing 1A9 or 2C3 revealed that 1A9 and 2C3 stain intraneuronal granules accumulated in the perikaryon of pyramidal neurons and some diffuse plaques. Fluoro Jade-B binding assay also revealed 1A9- or 2C3-stained neurons, indicating their impending degeneration. In a long-term low-dose prophylactic trial using active 1A9 or 2C3 antibody, we found that passive immunization protected a mouse model of Alzheimer's disease (AD) from memory deficits, synaptic degeneration, promotion of intraneuronal AβOs, and neuronal degeneration. Because the primary antitoxic action of 1A9 and 2C3 occurs outside neurons, our results suggest that extracellular AβOs initiate the AD toxic process and intraneuronal AβOs may worsen neuronal degeneration and memory loss. Conclusion: Now, we have evidence that HMW-AβOs are among the earliest manifestation of the AD toxic process in mice and humans. We are certain that our studies move us closer to our goal of finding a therapeutic target and/or confirming the relevance of our therapeutic strategy.Keywords
This publication has 36 references indexed in Scilit:
- Amyloid seeds formed by cellular uptake, concentration, and aggregation of the amyloid-beta peptideProceedings of the National Academy of Sciences, 2009
- Isolation and Characterization of Patient-derived, Toxic, High Mass Amyloid β-Protein (Aβ) Assembly from Alzheimer Disease BrainsJournal of Biological Chemistry, 2009
- Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memoryNature Medicine, 2008
- Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomersMolecular Neurodegeneration, 2007
- A Ganglioside-induced Toxic Soluble Aβ AssemblyJournal of Biological Chemistry, 2007
- Natural oligomers of the amyloid-β protein specifically disrupt cognitive functionNature Neuroscience, 2004
- Dimeric Amyloid β Protein Rapidly Accumulates in Lipid Rafts followed by Apolipoprotein E and Phosphorylated Tau Accumulation in the Tg2576 Mouse Model of Alzheimer's DiseaseThe Journal of Neuroscience, 2004
- Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of PathogenesisScience, 2003
- Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's DiseaseThe American Journal of Pathology, 1999
- Characterization of Apolipoprotein J-Alzheimer's Aβ InteractionJournal of Biological Chemistry, 1995